Cell and gene therapies are also a key part of Astellas’s growth strategy, building off of its 2020 acquisition of gene therapy developer Audentes Therapeutics. Within gene therapy, the Tokyo ...

US President Donald Trump announced plans to impose tariffs on imported computer chips pharmaceuticals and steel aiming to ...

The drugmaker sees additional growth opportunities in ophthalmology and neuromuscular disorders, Chief Medical Officer Tadaaki Taniguchi said.

Astellas is to work with UK biotech Adaptimmune ... and chimeric antigen receptors (CARs), important building blocks for cell therapies.. Based in Oxfordshire, Adaptimmune also has human leukocyte ...

The company said in its third-quarter results call that it is already building commercial manufacturing capacity for zolbetuximab as it anticipates the readout of the two phase 3 trials. Astellas ...

While it is building a $65 billion manufacturing facility in Arizona ... Imposing tariffs on imported pharmaceuticals could ...

GC Labs, a leading clinical laboratory in South Korea, announced the successful completion of the second day of the Medlab Middle East 2025, which is being held at the Dubai World Trade Centre (DWTC), ...

In the field of biopharmaceuticals, every technological innovation has the potential to revolutionize treatment strategies. Sanyou Bio's Intelligent Hundred-Trillion Molecule Library (AI-STAL) has ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Financial writer recommends Voyager Therapeutics, Inc. for high-risk investors due to promising preclinical Alzheimer's ...